Michelle T. Long, MD, MSc is the International Medical Vice President for Liver Diseases at Novo Nordisk. Dr. Long has experience in clinical hepatologist and gastroenterologist and previously worked as a physician scientist at Boston University School of Medicine. She has expertise in the overlap between MASH and cardiometabolic disease, cirrhosis, epidemiology, biomarkers, risk stratification, and care pathways.